Interviews
View More
Navigating the AD Treatment Landscape

Dr Neal Bhatia explains the available treatment options for patients with AD, including their relation to guideline recommendations.

Diagnosing Severe Atopic Dermatitis

Neal Bhatia, MD, provides an overview of atopic dermatitis (AD) and the diagnostic process, as well as how its severity impacts the patient.

Individualizing UF Therapy

Drs Al-Hendy and Lopes conclude with final thoughts on GnRH receptor antagonists, relugolix and elagolix, changing the UF treatment landscape.

Addressing Unmet Needs in UF

Dr Al-Hendy discusses what it takes to individualize UF treatment for each patient.

Biden Administration’s Healthcare Priorities and the Build Back Better Act, per Ryan Urgo of Avalere

Ryan Urgo, Managing Director, Health Policy at Avalere addressed the Biden administration’s healthcare priorities and if the Build Back Better legislation will include provisions that deal with drug prices? Urgo spoke at this year's annual Asembia Specialty Pharmacy Summit in Las Vegas on the subject, as well.

Jayne Hornung of MMIT Talks Digital Therapeutics at Asembia

Jayne Hornung, Chief Clinical Officer, Pharmacy, MMIT addresses the difference between digital therapeutics in the pharmacy and medical benefit space, and digs into the potential causes of the slow uptake in digital therapeutics among payers during this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Doug Long of IQVIA Gives an Outlook on the Specialty Pharmacy Industry at Asembia

Doug Long, vice president of Industry Relations at IQVIA spoke on how the current inflationary trend in the economy affects healthcare spending and prices, as well as the trend of specialty drugs accounting for half of the drug spend in healthcare. Hear more of what he shared with our team at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Jayson Slotnik of Health Policy Strategies, Inc Discusses Value-Based Contracting at Asembia 2022

Jayson Slotnik, partner at Health Policy Strategies, Inc, addresses the most recent developments in value-based contracting and how it affects specialty pharmacy at this year's Asembia Specialty Pharmacy Summit in Las Vegas.

Sonia Oskouei of Cardinal Health Discusses the Importance of Interchangeability for Biosimilars

Sonia Oskouei, PharmD, vice president of Biosimilars at Cardinal Health, spoke on pharmacists playing a bigger role in driving biosimilar adoption in 2023 and beyond during Asembia's 2022 Specialty Pharmacy Summit in Las Vegas.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences and PBMI. All rights reserved.